Key Points The healthcare diagnostics specialist posted its latest set of quarterly figures. This featured a surprise net profit, among other goodies. 10 stocks we like better than Exact Sciences › Cancer screening and diagnostics specialist Exact Sciences (NASDAQ: EXAS) was a standout stock on the second trading day of the week. Eager investors piled into it to leave it with a nearly 4% gain in price over the trading session, on a day when the S&P 500 (SNPINDEX: ^GSPC) suffered a 1.2% decline. Si ...